4.6 Article

Urban particulate matter stimulation of human dendritic cells enhances priming of naive CD8 T lymphocytes

Journal

IMMUNOLOGY
Volume 153, Issue 4, Pages 502-512

Publisher

WILEY
DOI: 10.1111/imm.12852

Keywords

CD8(+) T lymphocyte; dendritic cells; granulocyte-macrophage colony-stimulating factor; granzyme; lung; particulate matter

Categories

Funding

  1. Wellcome Trust [098882/Z/12/Z]
  2. National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust
  3. NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust
  4. King's College London
  5. Asthma UK [08/019, MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish
  6. Medical Research Council [G1000758, G1000758B] Funding Source: researchfish
  7. Wellcome Trust [098882/Z/12/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Epidemiological studies have consistently shown associations between elevated concentrations of urban particulate matter (UPM) air pollution and exacerbations of asthma and chronic obstructive pulmonary disease, which are both associated with viral respiratory infections. The effects of UPM on dendritic cell (DC) -stimulated CD4 T lymphocytes have been investigated previously, but little work has focused on CD8 T-lymphocyte responses despite their importance in anti-viral immunity. To address this, we examined the effects of UPM on DC-stimulated naive CD8 T-cell responses. Expression of the maturation/activation markers CD83, CCR7, CD40 and MHC class I on human myeloid DCs (mDCs) was characterized by flow cytometry after stimulation with UPMin vitro in the presence/absence of granulocyte-macrophage colony-stimulating factor (GM-CSF). The capacity of these mDCs to stimulate naive CD8 T-lymphocyte responses in allogeneic co-culture was then assessed by measuring T-cell cytokine secretion using cytometric bead array, and proliferation and frequency of interferon- (IFN-)-producing T lymphocytes by flow cytometry. Treatment of mDCs with UPM increased expression of CD83 and CCR7, but not MHC class I. In allogeneic co-cultures, UPM treatment of mDCs enhanced CD8 T-cell proliferation and the frequency of IFN-(+) cells. The secretion of tumour necrosis factor-, interleukin-13, Granzyme A and Granzyme B were also increased. GM-CSF alone, and in concert with UPM, enhanced many of these T-cell functions. The PM-induced increase in Granzyme A was confirmed in a human experimental diesel exposure study. These data demonstrate that UPM treatment of mDCs enhances priming of naive CD8 T lymphocytes and increases production of pro-inflammatory cytokines. Such UPM-induced stimulation of CD8 cells may potentiate T-lymphocyte cytotoxic responses upon concurrent airway infection, increasing bystander damage to the airways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Rachael A. Evans, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Raminder Aul, Paul Beirne, Charlotte E. Bolton, Jeremy S. Brown, Gourab Choudhury, Nawar Diar Bakerly, Nicholas Easom, Carlos Echevarria, Jonathan Fuld, Nick Hart, John R. Hurst, Mark Jones, Dhruv Parekh, Paul Pfeffer, Najib M. Rahman, Sarah Rowland-Jones, Ajay M. Shah, Dan G. Wootton, Trudie Chalder, Melanie J. Davies, Anthony De Soyza, William Greenhalf, Neil J. Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, R. Gisli Jenkins, Janet M. Lord, Will D-C Man, Gerry P. McCann, Stefan Neubauer, Peter J. M. Openshaw, Joanna Porter, Jennifer Quint, Matthew J. Rowland, Janet T. Scott, Malcolm G. Semple, Sally J. Singh, Mark Toshner, Keir Lewis, Andrew Briggs, Annemarie B. Docherty, Steven Kerr, Nazir Lone, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Ewen M. Harrison, Louise Wain, Christopher E. Brightling

Summary: This study aimed to describe recovery one year after hospital discharge for COVID-19 and identify potential therapeutic targets by analyzing inflammatory profiles. The results showed that a significant proportion of patients did not fully recover one year after discharge. Female sex, obesity, and invasive mechanical ventilation were associated with lower likelihood of full recovery. Inflammation and obesity may be treatable traits that need further investigation in clinical trials.

LANCET RESPIRATORY MEDICINE (2022)

Letter Allergy

Reply to Ethnicity-based differences in asthma diagnostic thresholds

John Busby, Liam G. Heaney, Paul E. Pfeffer

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Primary Health Care

Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London

Anna De Simoni, Hajar Hajmohammadi, Paul Pfeffer, Jim Cole, Chris Griffiths, Sally A. Hull

Summary: This study found that over 25% of patients with asthma were prescribed more than 6 SABA inhalers in a year. Prescription modality, asthma severity, and comorbidities are independent predictors of SABA overprescribing.

BRITISH JOURNAL OF GENERAL PRACTICE (2022)

Article Allergy

Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion

Adel H. Mansur, Sherif Gonem, Thomas Brown, Hassan Burhan, Rekha Chaudhuri, James W. Dodd, Thomas Pantin, Robin Gore, David Jackson, Andrew Menzies-Gow, Mitesh Patel, Ian Pavord, Paul Pfeffer, Salman Siddiqui, John Busby, Liam G. Heaney

Summary: Significant variation and divergence in the prescribing practices of biologics in severe asthma were observed through analysis of the UK Severe Asthma Registry and survey of severe asthma specialists' opinion.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Article Medicine, General & Internal

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Felicity Liew, Shubha Talwar, Andy Cross, Brian J. Willett, Sam Scott, Nicola Logan, Matthew K. Siggins, Dawid Swieboda, Jasmin K. Sidhu, Claudia Efstathiou, Shona C. Moore, Chris Davis, Noura Mohamed, Jose Nunag, Clara King, A. A. Roger Thompson, Sarah L. Rowland-Jones, Annemarie B. Docherty, James D. Chalmers, Ling-Pei Ho, Alexander Horsley, Betty Raman, Krisnah Poinasamy, Michael Marks, Onn Min Kon, Luke Howard, Daniel G. Wootton, Susanna Dunachie, Jennifer K. Quint, Rachael A. Evans, Louise V. Wain, Sara Fontanella, Thushan I. de Silva, Antonia Ho, Ewen Harrison, J. Kenneth Baillie, Malcolm G. Semple, Christopher Brightling, Ryan S. Thwaites, Lance Turtle, Peter J. M. Openshaw

Summary: This study examined the nasal and plasma antibody responses in COVID-19 hospitalized patients one year after discharge and vaccination. The findings showed sustained elevated antibody responses in both nasal and plasma samples for at least 12 months, but the nasal antibody response was minimally influenced by vaccination. These findings highlight the importance of developing vaccines that enhance nasal immunity.

EBIOMEDICINE (2023)

Article Education, Scientific Disciplines

Integration of respiratory physiology and clinical reasoning in the early years of a medical curriculum: engaging with students in a large classroom setting

Amir Hakim, William Ricketts, Paul Pfeffer, Rachel Ashworth

Summary: Medical graduates need to understand the scientific principles behind diseases and apply them in practice. Integrated medical curricula that combine biomedical science with clinical cases can enhance student learning, but students may have lower confidence in their knowledge. This study used an audience response system to engage students in active learning, with a focus on respiratory medicine. The results showed high student engagement and improved confidence in clinical reasoning.

ADVANCES IN PHYSIOLOGY EDUCATION (2023)

Article Allergy

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

Paul E. Pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik., Trung N. Tran, Jorge Maspero, Matthew Peters, George C. Christoff, Mohsen Sadatsafavi, Carlos A. Torres-Duque, Alan Altraja, Lauri Lehtimaki, Nikolaos G. Papadopoulos, Sundeep Salvi, Richard W. Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al-Ahmad, Desiree Larenas-Linnemann, Piotr Kuna, Joao A. Fonseca, Riyad Al-Lehebi, Chin Kook Rhee, Luis Perez-de-Llano, Diahn-Warng Perng Steve, Bassam Mahboub, Eileen Wang, Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Andrey S. Belevskiy, Mohit Bhutani, Leif Bjermer, Unnur Bjornsdottir, Arnaud Bourdin, Anna von Boulow, John Busby, Giorgio Walter Canonica, Borja G. Cosio, Delbert R. Dorscheid, Mariana Munoz-Esquerre, J. Mark FitzGerald, Esther Garcia Gil, Peter G. Gibson, Liam G. Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David J. Jackson, Mariko Siyue Koh, Hsin-Kuo Bruce Ko, Jae Ha Lee, Sverre Lehmann, Claudia Chaves Loureiro, Dora Ludviksdottir, Andrew N. Menzies-Gow, Patrick Mitchell, Andriana I. Papaioannou, Todor A. Popov, Celeste M. Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taille, Christian Taube, Yuji Tohda, Michael E. Wechsler, David B. Price

Summary: This study aimed to describe the profile of severe asthma patients eligible for both anti-IgE and anti-IL5/5R and compare the effectiveness of these two treatments in real-life settings. The results showed that anti-IL5/5R was superior to anti-IgE in reducing asthma exacerbations and long-term oral corticosteroid use, while there was some evidence suggesting a decrease in asthma-related hospitalizations with anti-IL5/5R treatment.

ALLERGY (2023)

Article Medicine, General & Internal

Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study

Sarah Walker, Henry Goodfellow, Patra Pookarnjanamorakot, Elizabeth Murray, Julia Bindman, Ann Blandford, Katherine Bradbury, Belinda Cooper, Fiona L. Hamilton, John R. Hurst, Hannah Hylton, Stuart Linke, Paul Pfeffer, William Ricketts, Chris Robson, Fiona A. Stevenson, David Sunkersing, Jiunn Wang, Manuel Gomes, William Henley

Summary: This study aimed to describe the characteristics and symptoms of treatment-seeking patients with post-COVID-19 syndrome (PCS) and assess the impact of these symptoms on health-related quality of life (HRQoL) and ability to work. The results showed that a high proportion of patients had moderately severe functional limitations, with fatigue being the dominant symptom. This study suggests that clinical care and rehabilitation should focus on managing fatigue.

BMJ OPEN (2023)

Article Immunology

Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma

Ilaria Esposito, Ioanna Kontra, Chiara Giacomassi, Sotiria Manou-Stathopoulou, James Brown, Richard Stratton, Galateia Verykokou, Roberto Buccafusca, Michael Stevens, Ahuva Nissim, Myles J. Lewis, Paul E. Pfeffer

Summary: This study found that severe eosinophilic asthma (SEA) patients have ANCA-positive IgG antibodies against neutrophils, suggesting a potential autoimmune etiology. ELISA results showed significantly higher concentrations of autoantibodies to Collagen-V, MPO, and TREM1 in SEA patients compared to healthy controls. These findings suggest that autoantibody serology research may improve diagnostic testing for severe asthma.

FRONTIERS IN IMMUNOLOGY (2023)

Article Allergy

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim W. Harrison, Pascal Chanez, Francesco Menzella, George Philteos, Borja G. Cosio, Njira L. Lugogo, Gustavo de Luiz, Annie Burden, Timothy Adlington, Nanna Keeling, Justin Kwiatek, Esther Garcia Gil

Summary: This study demonstrates the ability of benralizumab to improve asthma control and allow for a reduction in background medications.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Health Care Sciences & Services

Experiences of Diagnosis, Symptoms, and Use of Reliever Inhalers in Patients With Asthma and Concurrent Inducible Laryngeal Obstruction or Breathing Pattern Disorder: Qualitative Analysis of a UK Asthma Online Community

Catrin Byrne, Paul E. Pfeffer, Anna De Simoni

Summary: The study explored the discussion of ILO and BPD symptoms in a UK asthma online health community and patient experiences of diagnosis and treatment. The results showed that many patients were frustrated with the one-size-fits-all approach to diagnosis, and some suspected or were formally diagnosed with BPD or ILO, reporting relief on receiving a diagnosis and appropriate management. The online community provided comfort and prompted action with some going back to their clinicians for a diagnosis and appropriate treatment.

JOURNAL OF MEDICAL INTERNET RESEARCH (2023)

Review Medicine, General & Internal

Understanding interventions delivered in the emergency department targeting improved asthma outcomes beyond the emergency department: an integrative review

Imogen Skene, Emma Kinley, Katherine Pike, Chris Griffiths, Paul Pfeffer, Liz Steed

Summary: This study aimed to review existing literature on interventions delivered in the emergency department (ED) for adults and adolescents with asthma, beyond acute exacerbation management. The results suggest that ED-based asthma interventions may be effective in improving long-term outcomes. However, there is a need for standardized interventions, reported outcomes, and longer follow-up periods. Future interventions could benefit from utilizing behavior change theories, such as the Theoretical Domains Framework.

BMJ OPEN (2023)

Article Critical Care Medicine

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Betty Raman, Celeste McCracken, Mark P. Cassar, Alastair J. Moss, Lucy Finnigan, Azlan Helmy A. Samat, Godwin Ogbole, Elizabeth M. Tunnicliffe, Fidel Alfaro-Almagro, Ricarda Menke, Cheng Xie, Fergus Gleeson, Elena Lukaschuk, Hanan Lamlum, Kevin McGlynn, Iulia A. Popescu, Zeena-Britt Sanders, Laura Saunders, Stefan K. Piechnik, Vanessa M. Ferreira, Chrysovalantou Nikolaidou, Najib M. Rahman, Ling-Pei Ho, Victoria C. Harris, Aarti Shikotra, Amisha Singapuri, Paul Pfeffer, Charlotte Manisty, Onn Min Kon, Mark Beggs, Declan P. O'Regan, Jonathan Fuld, Jonathan R. Weir-McCall, Dhruv Parekh, Rick Steeds, Krisnah Poinasamy, Dan J. Cuthbertson, Graham J. Kemp, Malcolm G. Semple, Alexander Horsley, Christopher A. Miller, Caitlin O'Brien, Ajay M. Shah, Amedeo Chiribiri, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Marco Sereno, Ruth M. Saunders, Linzy Houchen-Wolloff, Neil J. Greening, Charlotte E. Bolton, Jeremy S. Brown, Gourab Choudhury, Nawar Diar Bakerly, Nicholas Easom, Carlos Echevarria, Michael Marks, John R. Hurst, Mark G. Jones, Daniel G. Wootton, Trudie Chalder, Melanie J. Davies, Anthony De Soyza, John R. Geddes, William Greenhalf, Luke S. Howard, Joseph Jacob, William D-C Man, Peter J. M. Openshaw, Joanna C. Porter, Matthew J. Rowland, Janet T. Scott, Sally J. Singh, David C. Thomas, Mark Toshner, Keir Lewis, Liam G. Heaney, Ewen M. Harrison, Steven Kerr, Annemarie B. Docherty, Nazir I. Lone, Jennifer K. Quint, Aziz Sheikh, Bang Zheng, Gisli Jenkins, Eleanor F. Cox, Susan Francis, Mark Halling-Brown, James D. Chalmers, John P. Greenwood, Sven Plein, Paul J. C. Hughes, A. A. Roger Thompson, Sarah Rowland-Jones, James M. Wild, Matthew Kelly, Thomas A. Treibel, Steven Bandula, Raminder Aul, Karla Miller, Peter Jezzard, Stephen Smith, Thomas E. Nichols, Gerry P. McCann, Rachael A. Evans, Louise V. Wain, Christopher E. Brightling, Stefan Neubauer

Summary: The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. This study aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures. The findings highlight the need for proactive multidisciplinary care pathways with imaging playing a potential role in guiding surveillance and treatment strategies.

LANCET RESPIRATORY MEDICINE (2023)

Article Respiratory System

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)

Florence Tydeman, Paul E. Pfeffer, Giulia Vivaldi, Hayley Holt, Mohammad Talaei, David Jolliffe, Gwyneth Davies, Ronan A. Lyons, Christopher Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Adrian R. Martineau

Summary: The relaxation of COVID-19 restrictions led to a decrease in face covering use, an increase in social mixing, and a rebound in acute respiratory infections and asthma exacerbations.

THORAX (2023)

Article Allergy

Bringing the treatable traits approach to primary care asthma management

Paul E. Pfeffer, Hitasha Rupani, Anna De Simoni

Summary: Asthma is a common disease that is often treated with a one-size-fits-all approach, but adopting a treatable traits approach could improve patient outcomes. While there are feasible implementation measures in primary care, further research is needed to guide the management of different treatable traits across care settings.

FRONTIERS IN ALLERGY (2023)

No Data Available